Eman Ahmed

14PUBLICATIONS
81CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Cellular nervous systemNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 28, 2026
Inhibition of Translesion DNA Synthesis Sensitizes BRCA-Deficient Ovarian Cancer to PARP Inhibitors.

|Mar 02, 2026
Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine Bioavailability.

Nadeen Anabtawi, Thomas Drabison, Alexander F Ham

|Aug 22, 2025
Drug-Drug Interaction Liabilities with BTK Inhibitor TL-895.

Jack C Stromatt, Eman A Ahmed, Thomas Drabison

|Jul 12, 2025
A Pilot Metabolomic Study for Diagnosing Aspergillus Infection in Immunocompromised Pediatric Cancer Patients.

Taghreed Khaled Abdelmoneim, Asmaa Ramzy, Mostafa Ahmed Zaki

|Apr 02, 2025
The Possible Role of Metformin and Fibroblast Growth Factor-21 in Multiple Sclerosis Neuropathology: Birds of a Feather Flock Together.

Ahmad A Abulaban, Hayder M Al-Kuraishy, Ali I Al-Gareeb

|Mar 10, 2025
OATP1B-type Transport Function Is a Determinant of Aromatase Inhibitor-Associated Arthralgia Susceptibility.

Hanieh Taheri, Yang Li, Kevin M Huang

Pageof 3

Frequent Collaborators

5 joint publications

Sameh Magdeldin

3 joint publications

Alex Sparreboom

3 joint publications

Thomas Drabison

2 joint publications

Daelynn R Buelow